የካንሰር ፋውንዴሽን መከላከል^® ዘጠኝ አዳዲስ የምርምር ድጋፎችን ይሸልማል

ለፈጣን መልቀቅ
እውቂያ: ሊዛ ቤሪ ኤድዋርድስ
703-519-2107
Lisa.Edwards@preventcancer.org

Alexandria, VA—The Prevent Cancer Foundation is pleased to announce funding for nine scientists who are researching cancer prevention and early detection. Each scientist is being awarded $100,000 for two years. Areas of focus include the pancreas, esophagus, liver, lungs, skin, prostate, colon-rectum, and blood/bone marrow.

Here are the 2021 research grantees. Click here for more detailed information on their projects.

ስጦታ ሰጪ፡  Limor Appelbaum, M.D.
የተሰየመ ሽልማት፡- ግሩም ጨዋታዎች በፍጥነት ተከናውነዋል
አቀማመጥ፡- Staff Scientist
ተቋም: Beth Israel Deaconess Medical Center, Boston, MA
የፕሮጀክት ርዕስ: Use of medical records and microbiome for predicting pancreatic cancer

Pancreatic cancer is usually diagnosed in advanced stages when cure is no longer possible. Early detection of this cancer can lead to cure. Dr. Appelbaum proposes a model that can identify people at high risk of pancreatic cancer to be recommended for screening, which can potentially save lives.

ስጦታ ሰጪ፡ Julie A. Barta, M.D., A.T.S.F.
የተሰየመ ሽልማት፡- Richard C. Devereaux የላቀ የወጣት መርማሪ ሽልማት
አቀማመጥ፡- Assistant Professor of Medicine
ተቋም፡ Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA
Application Title: Improving lung cancer screening barriers for vulnerable populations

Despite the advent of lung screening to identify cancers at early, curable stages, major disparities exist in screening uptake and adherence. This project will examine and alleviate financial and technological barriers for vulnerable populations to increase lung cancer early detection and survival rates.

ስጦታ ሰጪ፡ Neil Box, Ph.D.
አቀማመጥ፡- ተባባሪ ፕሮፌሰር
ተቋም: University of Colorado Denver, Anschutz Medical Campus and Denver Campus, Denver, CO
የፕሮጀክት ርዕስ፡- Integrating sun damage indicators in melanoma risk modeling

Dr. Box and his team will study how skin damaged by ultraviolet radiation can predict melanoma risk in children of certain genetic makeup. Their work will identify high-risk groups and prove the value of our tools in personalized melanoma prediction and prevention.

ስጦታ ሰጪ፡ Sigrid Carlsson, M.D., Ph.D., M.P.H.
የተሰየመ ሽልማት፡- ግሩም ጨዋታዎች በፍጥነት ተከናውነዋል
አቀማመጥ፡- Assistant Attending Epidemiologist
ተቋም፡ Memorial Sloan Kettering የካንሰር ማዕከል, ኒው ዮርክ, NY
Application Title: Improving prostate cancer screening using innovative technology

Dr. Carlsson and her team developed an innovative computer technology to help primary care physicians use “smarter” screening for prostate cancer for men who are most likely to benefit. The aim of this study is to test the usefulness of this computerized decision support tool in a large primary care network.

ስጦታ ሰጪ፡ Margie Clapper, Ph.D.
አቀማመጥ፡- Deputy Scientific Director/Professor/Co-Leader, Cancer Prevention and Control Program
ተቋም: The Research Institute of Fox Chase Cancer Center, Philadelphia, PA
የፕሮጀክት ርዕስ፡- Impact of atorvastatin with or without aspirin on colorectal biomarkers in patients with Lynch Syndrome: a pilot study

Lynch Syndrome (LS) is the most common genetic cause of colon cancer in people under age 50. Atorvastatin reduces colon microadenomas dramatically in mice. Understanding the effect of atorvastatin with or without aspirin on colon biomarkers is critical to developing a preventive therapy for LS patients.

ስጦታ ሰጪ፡ William Grady, M.D.
የተሰየመ ሽልማት፡- የሹሬ ቤተሰብ የበጎ አድራጎት ድርጅት
አቀማመጥ፡- ፕሮፌሰር
ተቋም፡ Fred Hutchinson Cancer Research Center, Seattle, WA
የፕሮጀክት ርዕስ፡- Dysbiotic esophageal microbiomes and esophageal cancer risk

These studies have the potential to identify cancer-causing esophageal bacteria, which could lead to novel and improved ways to prevent cancer through more accurate cancer risk prediction. The studies could also lead to novel antibiotic or probiotic cancer prevention treatments for esophageal cancer.

Fellow: Natalia Heredia, Ph.D., M.P.H.
አቀማመጥ፡- ረዳት ፕሮፌሰር
ተቋም፡ The University of Texas Health Science Center, Houston, TX 
የተሰየመ ሽልማት፡- ማርሲያ እና ፍራንክ ካርሉቺ የበጎ አድራጎት ድርጅት
የፕሮጀክት ርዕስ፡- Culturally tailored lifestyle intervention for Hispanic non-alcoholic fatty liver disease

The rate of new cases of liver cancer continues to increase in Hispanics, partially due to a condition called non-alcoholic fatty liver disease (NAFLD). Treatment for NAFLD includes weight loss, so by helping Hispanic NAFLD patients lose weight, we can prevent future cases of NAFLD-related liver cancer.

ስጦታ ሰጪ፡ Maro Ohanian, D.O.
ሽልማት ተሰይሟል: Triad Foundation, LLC
አቀማመጥ፡- ረዳት ፕሮፌሰር
ተቋም: University of Texas M.D. Anderson Cancer Center, Houston, TX
የፕሮጀክት ርዕስ፡- Detoxification of environmental metals to prevent acute myeloid leukemia

Toxic metals are a modifiable risk factor associated with increased cancer risk. Dr. Ohanian aims to reverse carcinogenic effects of environmental/occupational metal exposures that can lead to acute myeloid leukemia (AML) by detoxifying metals in patients with myelodysplastic syndrome (pre-leukemia) as a novel cancer prevention method.

Fellow: Aayushi Uberoi, Ph.D.
የተሰየመ ሽልማት፡- ግሩም ጨዋታዎች በፍጥነት ተከናውነዋል
አቀማመጥ፡- Postdoctoral Scholar
ተቋም: University of Pennsylvania, Philadelphia, PA
የፕሮጀክት ርዕስ፡- Modulating skin microbiota-host interactions to prevent UV-induced skin cancer

While the skin microbiome encounters the same ultraviolet B (UVB) exposure as the skin, the effects of UVB on the skin microbiome is unexplored. By exploring host-microbiome interactions during UVB-associated skin cancers, we can uncover a novel class of biomarkers and therapeutics for prevention of skin cancer.

ስለ ካንሰር መከላከል ፋውንዴሽን^®

የካንሰር መከላከያ ፋውንዴሽን^® የዩናይትድ ስቴትስ ብቸኛው ለትርፍ ያልተቋቋመ ድርጅት ካንሰርን በመከላከል እና አስቀድሞ በመለየት ህይወቶችን በማዳን ላይ ብቻ ያተኮረ 35 ዓመታትን እያከበረ ነው። በምርምር፣ ትምህርት፣ ተደራሽነት እና ድጋፍ፣ ስፍር ቁጥር የሌላቸው ሰዎች የካንሰር ምርመራ እንዳይደረግባቸው ወይም ካንሰርን በተሳካ ሁኔታ እንዲታከሙ ቀድመን እንዲያውቁ ረድተናል።

ፋውንዴሽኑ በ2035 የካንሰር ሞትን በ401ቲፒ3ቲ በመቀነስ ላይ ያለውን ፈተና ለመቋቋም $20 ሚሊዮን ለፈጠራ ቴክኖሎጂዎች በማፍሰስ ካንሰርን ቀድመን በመለየት የብዝሃ ካንሰር ምርመራን ለማስፋፋት $10 ሚሊዮን የካንሰር ምርመራና ክትባቱን ለማስፋፋት ቁርጠኛ ነው። በህክምና ያልተጠበቁ ማህበረሰቦችን ማግኘት፣ እና $10 ሚሊዮን ስለማጣሪያ እና የክትባት አማራጮች ህዝቡን ለማስተማር።

ለበለጠ መረጃ፣ እባክዎን ይጎብኙ www.preventcancer.org.